ACI
CBPO

AMP Capital Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

AMP Capital Investors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-26,472
Closed -$2.85M – 1260
2016
Q4 		$2.85M Sell
26,472
-2,852
-10% -$333K 0.02% 658
2016
Q3 		$3.63M Sell
29,324
-1,565
-5% -$185K 0.02% 593
2016
Q2 		$3.27M Buy
30,889
+24,289
+368% +$2.82M 0.02% 591
2016
Q1 		$754K Buy
+6,600
New +$774K 0.01% 885

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AMP Capital Investors's CBPO Position: Q1 2017 in Review

AMP Capital Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 26,472 shares — an estimated $2.85M sold.

AMP Capital Investors first reported a position in CBPO in Q1 2016 and held it in 4 quarters. The position peaked at $3.63M in Q3 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

  • AMP Capital Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
  • AMP Capital Investors sold 26,472 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $2.85M.
  • AMP Capital Investors first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 4 quarters.
  • AMP Capital Investors's China Biologic Products Holdings, Inc. position peaked at $3.63M in Q3 2016.
  • 137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on AMP Capital Investors's 13F filing for Q1 2017, filed 15 May 2017.